Carl B. Feldbaum - 09 Feb 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role: Director
Signature: /s/ Nina Ayer, Attorney in Fact
Issuer symbol: EXEL
Transactions as of: 09 Feb 2023
Net transactions value: -$459,200
Form type: 4
Filing time: 10 Feb 2023, 18:56:16 UTC
Previous filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXEL	Common Stock	Options Exercise	$252,000	+40,000	+214%	$6.30	58,701	09 Feb 2023	Direct	F1
transaction	EXEL	Common Stock	Sale	$711,200	-40,000	-68%	$17.78	18,701	09 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EXEL	Option (right to buy)	Options Exercise	$0	-40,000	-100%	$0.000000^*	0	09 Feb 2023	Common Stock	40,000	$6.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 10,180 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2	Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.76 to $17.82. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3	The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016.